Stock Information
Alumis Inc (ALMS)
Ticker Symbol: ALMS
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $1,415.16 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.81
Revenue (TTM): $0.04 M
Dividend Yield: N/A
ROE: -102.97%
Latest News
-
Alumis snags set of Phase III psoriasis pill victories, but analysts lukewarm on impact
Fri, Oct 9, 2026 5:11 PM
-
Alumis Announces New Phase 3 Data Demonstrating Envudeucitinib Rapidly and Durably Improved Psoriasis Burden Across Scalp, Itch, and Quality of Life Measures
Fri, Oct 9, 2026 8:00 AM
-
Alumis New Phase 3 ONWARD Data Show Envudeucitinib Improved Scalp, Itch And Quality Of Life In Psoriasis, Building On 54% PASI 100 At Week 48; NDA On Track For 4Q 2026
Fri, Oct 9, 2026 4:20 AM
-
Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to its Board of Directors
Thu, Oct 8, 2026 12:00 PM
Key Financials
Financial data not available
